García-Gareta Elena, Coathup Melanie J, Blunn Gordon W
RAFT Institute of Plastic Surgery, Mount Vernon Hospital, Northwood HA6 2RN, UK.
John Scales Centre for Biomedical Engineering, Institute of Orthopaedics and Musculoskeletal Science, Division of Surgery and Interventional Science, University College London, Royal National Orthopaedic Hospital, Stanmore HA7 4LP, UK.
Bone. 2015 Dec;81:112-121. doi: 10.1016/j.bone.2015.07.007. Epub 2015 Jul 8.
Regeneration of bone defects caused by trauma, infection, tumours or inherent genetic disorders is a clinical challenge that usually necessitates bone grafting materials. Autologous bone or autograft is still considered the clinical "gold standard" and the most effective method for bone regeneration. However, limited bone supply and donor site morbidity are the most important disadvantages of autografting. Improved biomaterials are needed to match the performance of autograft as this is still superior to that of synthetic bone grafts. Osteoinductive materials would be the perfect candidates for achieving this task. The aim of this article is to review the different groups of bone substitutes in terms of their most recently reported osteoinductive properties. The different factors influencing osteoinductivity by biomaterials as well as the mechanisms behind this phenomenon are also presented, showing that it is very limited compared to osteoinductivity shown by bone morphogenetic proteins (BMPs). Therefore, a new term to describe osteoinductivity by biomaterials is proposed. Different strategies for adding osteoinductivity (BMPs, stem cells) to bone substitutes are also discussed. The overall objective of this paper is to gather the current knowledge on osteoinductivity of bone grafting materials for the effective development of new graft substitutes that enhance bone regeneration.
由创伤、感染、肿瘤或先天性遗传疾病导致的骨缺损修复是一项临床挑战,通常需要骨移植材料。自体骨或自体移植物仍然被视为临床“金标准”以及骨再生的最有效方法。然而,骨供应有限和供区并发症是自体骨移植最重要的缺点。需要改进生物材料以匹配自体骨的性能,因为其性能仍优于合成骨移植材料。骨诱导材料将是完成这项任务的理想选择。本文旨在根据最近报道的不同骨替代物的骨诱导特性进行综述。还介绍了影响生物材料骨诱导性的不同因素以及这一现象背后的机制,结果表明与骨形态发生蛋白(BMP)所表现出的骨诱导性相比,生物材料的骨诱导性非常有限。因此,提出了一个描述生物材料骨诱导性的新术语。还讨论了向骨替代物添加骨诱导性(BMP、干细胞)的不同策略。本文的总体目标是收集有关骨移植材料骨诱导性的当前知识,以有效开发促进骨再生的新型移植替代物。